GRAINGER DAVID J has filed 8 insider transactions across 1 company since September 2022.
Most recent transaction: a tax payment of 4700 shares of Centessa Pharmaceuticals plc ($CNTA) on December 31, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2023 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | F | Ordinary Shares | 4700 | $7.96 | 990,290.0000 | 0 | 0.47% | 0.00% |
| Sept. 30, 2023 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | F | Ordinary Shares | 4700 | $6.47 | 994,990.0000 | 0 | 0.47% | 0.00% |
| June 30, 2023 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | F | Ordinary Shares | 4290 | $5.90 | 999,690.0000 | 0 | 0.43% | 0.00% |
| March 31, 2023 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | F | Ordinary Shares | 4825 | $3.90 | 1,003,980.0000 | 0 | 0.48% | 0.00% |
| Feb. 1, 2023 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | A | Ordinary Shares | 77200 | $0.00 | 1,008,805.0000 | 0 | 8.29% | 0.00% |
| Feb. 1, 2023 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | A | Share Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2022 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | F | Ordinary Shares | 7154 | $4.25 | 934,102.0000 | 0 | 0.76% | 0.00% |
| Dec. 31, 2022 | Centessa Pharmaceuticals plc | $CNTA | GRAINGER DAVID J | Chief Innovation Officer | F | Ordinary Shares | 2497 | $3.10 | 938,759.0000 | 0 | 0.27% | 0.00% |